An in vitro study on human colon cancer cell lines (HCT116 and Caco-2) showed that CB1R antagonists, particularly Rimonabant (SR141716) and AM251, may contribute to anticancer properties. The gene discussed is CNR1; the disease is malignant colon neoplasm.